Dashboard
Manage Tickers

ZNTL


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

zentalis-pharmaceuticals-announces-four-abstracts-on-its-wee1-inhibitor-azenosertib-have-been-accepted-for-poster-presentations-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-october-2226-2025-in-boston-massachusetts
Zentalis Pharmaceuticals Announces Four Ab...
10/13/2025 20:07:31

Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-cla...

wells-fargo-maintains-equal-weight-on-zentalis-pharma-lowers-price-target-to-5
Wells Fargo Maintains Equal-Weight on Zent...
08/07/2025 14:38:59

Wells Fargo analyst Derek Archila maintains Zentalis Pharma (NASDAQ:ZNTL) with a Equal-Weight and lowers the price target fr...

zentalis-pharma-q2-eps-037-beats-051-estimate-3034m-cash-cash-equivalents-and-marketable-securities-supports-operational-runway-into-late-2027
Zentalis Pharma Q2 EPS $(0.37) Beats $(0.5...
08/06/2025 20:52:54

wedbush-reiterates-neutral-on-zentalis-pharma-maintains-4-price-target
Wedbush Reiterates Neutral on Zentalis Pha...
05/15/2025 14:52:08

Wedbush analyst Robert Driscoll reiterates Zentalis Pharma (NASDAQ:ZNTL) with a Neutral and maintains $4 price target.

hc-wainwright--co-reiterates-buy-on-zentalis-pharma-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Zent...
05/15/2025 11:57:00

HC Wainwright & Co. analyst Andres Maldonado reiterates Zentalis Pharma (NASDAQ:ZNTL) with a Buy and maintains $10 price...

zentalis-pharma-q1-eps-067-misses-063-estimate
Zentalis Pharma Q1 EPS $(0.67) Misses $(0....
05/14/2025 20:20:09

Zentalis Pharma (NASDAQ:ZNTL) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0...

zentalis-pharmaceuticals-doses-first-patient-dosed-in-denali-part-2-clinical-trial-of-azenosertib-in-patients-with-cyclin-e1-proc
Zentalis Pharmaceuticals Doses First Patie...
04/28/2025 12:07:48

zentalis-pharmaceuticals-to-present-poster-at-2025-asco-annual-meeting
Zentalis Pharmaceuticals To Present Poster...
04/23/2025 20:08:26

wedbush-reiterates-neutral-on-zentalis-pharma-maintains-4-price-target
Wedbush Reiterates Neutral on Zentalis Pha...
03/28/2025 13:51:23

Wedbush analyst Robert Driscoll reiterates Zentalis Pharma (NASDAQ:ZNTL) with a Neutral and maintains $4 price target.

hc-wainwright--co-reiterates-buy-on-zentalis-pharma-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Zent...
03/27/2025 11:08:56

HC Wainwright & Co. analyst Andrew Fein reiterates Zentalis Pharma (NASDAQ:ZNTL) with a Buy and maintains $10 price target.

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/26/2025 21:05:44

zentalis-pharmaceuticals-inc-files-for-mixed-shelf-of-up-to-250m
Zentalis Pharmaceuticals Inc Files For Mix...
03/26/2025 20:21:30

- SEC Filing

zentalis-pharmaceuticals-fy24-eps-233-up-from-447-yoy
Zentalis Pharmaceuticals FY24 EPS ($2.33) ...
03/26/2025 20:08:38

hc-wainwright--co-reiterates-buy-on-zentalis-pharma-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Zent...
03/17/2025 11:14:32

HC Wainwright & Co. analyst Andrew Fein reiterates Zentalis Pharma (NASDAQ:ZNTL) with a Buy and maintains $10 price target.

reported-saturday-zentalis-presented-updated-denali-part-1b-clinical-data-demonstrating-63-month-mdor-and-35-orr-with-azenosertib-monotherapy-in-cyclin-e1-platinum-resistant-ovarian-cancer
Reported Saturday, Zentalis Presented Upda...
03/17/2025 07:17:25

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients w...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
02/05/2025 12:05:43

wells-fargo-maintains-equal-weight-on-zentalis-pharma-lowers-price-target-to-6
Wells Fargo Maintains Equal-Weight on Zent...
01/30/2025 23:33:48

Wells Fargo analyst Derek Archila maintains Zentalis Pharma (NASDAQ:ZNTL) with a Equal-Weight and lowers the price target fr...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
01/29/2025 21:06:37

hc-wainwright--co-maintains-buy-on-zentalis-pharma-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on Zenta...
01/29/2025 17:48:32

HC Wainwright & Co. analyst Andrew Fein maintains Zentalis Pharma (NASDAQ:ZNTL) with a Buy and lowers the price target f...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
01/29/2025 12:05:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION